SCPH icon

scPharmaceuticals
SCPH

Overview Fund Activity

51 hedge funds and large institutions have $129M invested in scPharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+18
Holders Change %
+54.55%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
20
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$35.3M
2
DCM
2
Driehaus Capital Management
Illinois
$5.51M
3
5VM
3
5AM Venture Management
California
$28.2M
4
IC
4
Ikarian Capital
Texas
$10.8M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$2.86M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$13K
2
Millennium Management
2
Millennium Management
New York
$0
3
BCM
3
Bridgeway Capital Management
Texas
$289K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
MC
5
Matisse Capital
Oregon
$130K
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$1.48K +$1.21K +165 +458%
Millennium Management
52
Millennium Management
New York
– -$259K -35,059 Closed
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
– -$87K -11,759 Closed
Victory Capital Management
54
Victory Capital Management
Texas
– -$40K -5,420 Closed
MAM
55
Meeder Asset Management
Ohio
– -$6K -729 Closed
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
– -$1K -117 Closed
1 2
3